חזרה לתוצאות החיפוש

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Lower Respiratory Tract Infection · Parainfluenza · Immunocompromised · COVID-19

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • City of Hope cancer Center, Duarte, California, United States

  • University of California Davis Health System, Sacramento, California, United States

    Contact: Study coordinator (Stuart Cohen, MD)
    Contact: Principal Investigator (Stuart Cohen, MD)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

  • University of Iowa Health Care, Iowa City, Iowa, United States

  • University of Kansas Medical Center, Fairway, Kansas, United States

  • The Johns Hopkins Hospital, Baltimore, Maryland, United States

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

    Contact: Principal Investigator (Paschalis Vergidis, MD)

  • Washington University, St Louis, Missouri, United States

  • Weill Cornell Medical College, New York, New York, United States

    Contact: Study coordinator (Rosypriya Kodiyanplakkal, MD)
    Contact: Principal Investigator (Rosypriya Kodiyanplakkal, MD)

  • Duke University, Durham, North Carolina, United States

    Contact: Study coordinator (Cameron Wolfe, MD)
    Contact: Principal Investigator (Cameron Wolfe, MD)

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

  • Oregon Health & Science University, Portland, Oregon, United States

  • University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States

  • UT Southwestern Medical Center, Dallas, Texas, United States

  • Baylor College of Medicine, Houston, Texas, United States

    Contact: Principal Investigator (Puneet Garcha)

  • MD Anderson, Houston, Texas, United States

  • VCU Health System, Richmond, Virginia, United States

    Contact: Study coordinator (Kristin Miller, MD) · kristin.miller@vcuhealth.org · 804-828-9041
    Contact: Principal Investigator (Kristin Miller, MD)

  • Seattle Children's Hospital, Seattle, Washington, United States

  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

  • Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

  • Froedtert Medical College Pulmonary Clinic, Milwaukee, Wisconsin, United States

  • Westmead Hospital, Sydney, New South Wales, Australia

  • Shanghai Pulmonary Hospital, Yangpu, Shanghai Municipality, China

  • Seoul National University Hospital, Seoul, Gyeonggi-do, South Korea

  • Samsung Medical Center, Seoul, Gyeonggi-do, South Korea

  • National Cheng Kung University Hospital, Tainan, Tainan, Taiwan

מובילי המחקר

  • Ronald B Moss, MD

    Study Chair

    Ansun Biopharma, Inc.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)